Bill Plovanic

Bill Plovanic is a Managing Director and Equity Research Medical Technology Analyst at Canaccord Genuity- Global Capital Markets.2 He is based in Fernandina Beach, Florida, United States, and has over 3,000 followers on LinkedIn.2 Plovanic is an experienced Wall Street Analyst focusing on the Healthcare sector, particularly medical technologies and devices.12

As an analyst, Plovanic covers 57 stocks in the Healthcare sector.1 His expertise lies in analyzing paradigm-changing technologies that are transforming healthcare.5 He is known for presenting at investor conferences in New York City, updating investors on recent developments in the medical technology field.4

Plovanic's performance as an analyst shows a 42% success rate, with 173 out of 415 ratings making a profit.1 His average return per rating is -2.80%.1 His most profitable rating was a "Buy" recommendation for Transmedics Group (TMDX) stock, which yielded a return of +360.50% between February 25, 2022, and February 25, 2023.1

At Canaccord Genuity, Plovanic is involved in the company's Annual Growth Conference, which brings together institutional investors from across the globe with promising companies.3 This event showcases his role in connecting investors with potential investment opportunities in the medical technology sector.